Amgen Announces Repatha® Preferred Position On CVS Health Commercial Formularies

Go back to Amgen Announces Repatha® Preferred Position On CVS Health Commercial Formularies
Amgen Inc (NASDAQ: AMGN) Delayed: 439.33 +5.60 (1.29%)
Previous Close $433.73    52 Week High $176.85 
Open $431.72    52 Week Low $133.64 
Day High $440.51    P/E 66.16 
Day Low $429.38    EPS $6.64 
Volume 2,114,126